PubRank

M M Hoeper

Author PubWeight™ 39.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009 6.64
2 Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation. Am J Transplant 2010 1.87
3 Endothelin receptor antagonists in pulmonary arterial hypertension. Eur Respir J 2008 1.77
4 Results of European post-marketing surveillance of bosentan in pulmonary hypertension. Eur Respir J 2007 1.32
5 The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension. Eur Respir J 2011 1.28
6 Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study. Eur Respir J 2010 1.28
7 Bridge to thoracic organ transplantation in patients with pulmonary arterial hypertension using a pumpless lung assist device. Am J Transplant 2009 1.15
8 Low frequency of BMPR2 mutations in a German cohort of patients with sporadic idiopathic pulmonary arterial hypertension. J Med Genet 2004 1.08
9 Combination therapy for pulmonary arterial hypertension: still more questions than answers. Eur Respir J 2004 1.06
10 Peripheral airway obstruction in primary pulmonary hypertension. Thorax 2002 0.95
11 The new definition of pulmonary hypertension. Eur Respir J 2009 0.93
12 Liver toxicity of sitaxentan in pulmonary arterial hypertension. Eur Respir J 2011 0.88
13 Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension. Eur Respir J 2001 0.88
14 Severe hepatitis associated with sitaxentan and response to glucocorticoid therapy. Eur Respir J 2009 0.87
15 Outcome measures in pulmonary arterial hypertension associated with systemic sclerosis. Rheumatology (Oxford) 2008 0.86
16 Liver toxicity: the Achilles' heel of endothelin receptor antagonist therapy? Eur Respir J 2009 0.84
17 Effects of inhaled salbutamol in primary pulmonary hypertension. Eur Respir J 2002 0.83
18 Increased xanthine oxidase activity in idiopathic pulmonary arterial hypertension. Eur Respir J 2009 0.83
19 Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs. Eur Respir J 1999 0.82
20 Lack of association between angiotensin converting enzyme (ACE) genotype, serum ACE activity, and haemodynamics in patients with primary pulmonary hypertension. Heart 2003 0.82
21 [Characteristics and management of idiopathic pulmonary fibrosis: INSIGHTS-IPF registry]. Dtsch Med Wochenschr 2012 0.81
22 [International, prospective register for the documentation of first-line and maintenance therapy in patients with pulmonary hypertension (CompERA-XL)]. Dtsch Med Wochenschr 2009 0.79
23 [Diagnosis and therapy of chronic pulmonary hypertension]. Pneumologie 2006 0.79
24 [Drug combination treatment for pulmonary arterial hypertension]. Dtsch Med Wochenschr 2006 0.78
25 [Histopathological aspects of pulmonary hypertension]. Pathologe 2012 0.78
26 [Targeted therapy of pulmonary arterial hypertension: Recommendations of the Cologne Consensus Conference 2016]. Dtsch Med Wochenschr 2016 0.77
27 [Chronic thromboembolic pulmonary hypertension: recommendations of the Cologne Consensus Conference 2010]. Dtsch Med Wochenschr 2010 0.77
28 Ambrisentan improves exercise capacity and symptoms in patients with portopulmonary hypertension. Z Gastroenterol 2011 0.77
29 Acute liver failure: a message found under the skin. Postgrad Med J 2005 0.77
30 The search for an oral prostanoid to treat pulmonary arterial hypertension continues. Are we getting any closer? Int J Clin Pract Suppl 2009 0.77
31 [Right heart catheterization in pulmonary hypertension]. Dtsch Med Wochenschr 2011 0.77
32 [Chronic thromboembolic pulmonary hypertension: Recommendations of the Cologne Consensus Conference 2016]. Dtsch Med Wochenschr 2016 0.77
33 Plasmapheresis in streptococcal toxic shock syndrome. Crit Care Med 2001 0.76
34 Overdose of metoprolol treated with enoximone. N Engl J Med 1996 0.76
35 [Diagnosis and therapy of chronic pulmonary hypertension]. Clin Res Cardiol 2007 0.75
36 Observational trials in pulmonary arterial hypertension: low scientific evidence but high clinical value. Eur Respir J 2007 0.75
37 Treatment of lympho-proliferative disease with rituximab. Lancet 2000 0.75
38 Extracorporeal lung assist: more than kicking a dead horse? Eur Respir J 2008 0.75
39 A message on the lips. Eur Respir J 2008 0.75
40 Long-term treatment of pulmonary hypertension with aerosolized iloprost. Eur Respir J 2001 0.75
41 Pulmonary hypertension: basic concepts and practical management. Eur Respir J 2008 0.75
42 Treating pulmonary hypertension in COPD: where do we start? Eur Respir J 2008 0.75
43 [Update: Current clinical developments in pulmonary hypertension]. Dtsch Med Wochenschr 2009 0.75
44 [Cologne Consenus Conference on pulmonary hypertension 2010. Guidelines for diagnosis and therapy of pulmonary hypertension]. Dtsch Med Wochenschr 2010 0.75
45 [Decompensated right heart failure, intensive care and perioperative management in patients with pulmonary hypertension]. Dtsch Med Wochenschr 2016 0.75
46 [Pulmonary arterial hypertension in collagenoses]. Z Rheumatol 2009 0.75
47 [Risk stratification and follow-up assessment of patients with pulmonary arterial hypertension: Recommendations of the Cologne Consensus Conference 2016]. Dtsch Med Wochenschr 2016 0.75
48 Azathioprine withdrawal in stable lung and heart/lung recipients receiving cyclosporine-based immunosuppression. Transplantation 2000 0.75
49 [Right heart failure in chronic pulmonary hypertension and acute pulmonary embolism]. Internist (Berl) 2012 0.75
50 [Treatment of pulmonary arterial hypertension (PAH): recommendations of the Cologne Consensus Conference 2010]. Dtsch Med Wochenschr 2010 0.75
51 [Pulmonary hypertension due to chronic lung disease: Recommendations of the Cologne Consensus Conference 2016]. Dtsch Med Wochenschr 2016 0.75
52 Pulmonary arterial hypertension: pathobiology, diagnosis and treatment. Minerva Med 2005 0.75
53 [Pulmonary complications of liver cirrhosis: hepatopulmonary syndrome, portopulmonary hypertension and hepatic hydrothorax]. Internist (Berl) 2010 0.75
54 Hemoptysis following left ventricular aneurysm repair: a misleading clinical sign. Chest 2000 0.75
55 "Treat-to-target" in pulmonary arterial hypertension and the use of extracorporeal membrane oxygenation as a bridge to transplantation. Eur Respir Rev 2011 0.75